Professional Documents
Culture Documents
It should be considered that the success or failure in the use of the luminescent
nanomaterials in these applications is largely determined by the ability to
bioconjugate such nanoparticles to specific recognition elements, such as aptamers or
antibodies, a mandatory previous step for the successful development of new
bioassay and bioanalytical applications based on biolabeling and bioimaging. Despite
recent progress in the use of QDs and NCs for bioanalytical applications, there is still
an urgent need for effective procedures for the nanomaterials bioconjugates
purification and characterization, in order to further facilitate reliable quantitative
bioassays.
Moreover, we will also describe our latest efforts of using metal nanoparticles lo
label proteins and so to amplify enormously the corresponding ICP-MS signals of the
bioconjugates NPs-antibodies targeting the protein(s) of interest for targeted
proteomics issues. The proof of concept of such novel approaches and application to
real-life simultaneous ICP-MS determinations of a panel of known proteins, to act as
"early alarm biomarkers" of ocular diseases (e.g. glaucoma), will be discussed [2].
References
[1] Diez Fernández S, Sugishama N, Ruiz Encinar J, Sanz-Medel A Anal Chem., 2012, 84: 5851-
5857.
[2] Montoro Bustos AR, Garcia-Cortes M, González-Iglesias H, Ruiz Encinar J, Costa-Fernández J.M,
Coca-Prados M, Sanz-Medel A Anal. Chim. Acta, 2015 doi: 10.10 16/j.aca.2015.03 .015.
27